YS Biopharma's High-Stakes Board Restructuring: The Coup and its Implications

Retrieved on: 2024-02-08 23:31:45

Tags for this article:

Click the tags to see associated articles and topics

YS Biopharma's High-Stakes Board Restructuring: The Coup and its Implications. View article details on hiswai:

Excerpt

YS Biopharma's upcoming EGM aims to remove 6 directors and appoint 4 new ones. Shareholders urged to vote by proxy.

Article found on: bnnbreaking.com